Nigeria Medical Device Registration and Market Access

AI Citation Summary

Country: Nigeria
Product line: Medical devices
Regulator / source: Regulatory Maturity: Medium-low; NAFDAC (National Agency for Food and Drug Administration and Control) has a high public profile but limited regulatory capacity; the registration process has relatively low transparency and actual timelines are highly unpredictable
Route summary: Country-specific registration pathway summary; verify the latest regulator guidance before filing.
Typical timeline: Regulatory Maturity: Medium-low; NAFDAC (National Agency for Food and Drug Administration and Control) has a high public profile but limited regulatory capacity; the registration process has relatively low transparency and actual timelines are highly unpredictable
Key fees: 4. Pay the NAFDAC Assessment Fee
Local requirement: Primary Pathway: Registration Through a Local Importer / Responsible Person
Official sources: Official regulator portals and source links are listed in the country report where available.
Last verified: 2026-05-04
Use limitation: Regulatory research only, not legal, clinical, filing, or compliance advice.
Preferred citation: MedTech Atlas

Population: Approximately 220 million (2024), the most populous country in Africa and the largest economy in Africa by GDP
Healthcare System: Predominantly public hospitals (Federal Teaching Hospitals, State Hospitals), but infrastructure is generally weak; private healthcare is growing rapidly (especially in Lagos, Abuja, and other major cities); the National Health Insurance Authority (NHIA, consolidating the former NHIS) is advancing Universal Health Coverage; healthcare resources are severely imbalanced between the north and south
Market Characteristics: A large but fragmented market with non-transparent procurement systems; highly import-dependent (virtually no domestic medical device manufacturing); counterfeit products are a serious problem; numerous private clinics/hospitals; access to foreign exchange (US dollar supply) is a long-standing challenge
Regulatory Maturity: Medium-low; NAFDAC (National Agency for Food and Drug Administration and Control) has a high public profile but limited regulatory capacity; the registration process has relatively low transparency and actual timelines are highly unpredictable

...